| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |